Related Experiment Video
Updated: Jun 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Energy Drinks: A Clinical Primer and National Data Update
Kevin Y Xu1, Kevin T Baumgartner2, Suraj Shankar3
1Assistant Professor, Division of Addiction Science, Prevention, and Treatment Science, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
This study estimates energy drink consumption in the US and offers harm reduction strategies for patients. It focuses on understanding potential harms rather than demanding complete abstinence for healthier choices.
Area of Science:
- Public Health
- Clinical Medicine
- Substance Use Research
Background:
- Energy drink consumption is a growing public health concern.
- Understanding national uptake patterns is crucial for targeted interventions.
- Clinical evaluation of unhealthy energy drink use requires specific strategies.
Purpose of the Study:
- To estimate energy drink uptake using national-level data in the US.
- To provide clinical strategies for evaluating patients with unhealthy energy drink consumption.
- To apply a harm reduction approach to energy drink consumption.
Main Methods:
- Analysis of national-level data on energy drink consumption in the US.
- Development of clinical strategies for patient evaluation.
- Application of harm reduction principles in patient care.
Main Results:
- Estimates of energy drink uptake are presented.
- Clinical strategies for evaluating unhealthy consumption are detailed.
- The harm reduction paradigm is applied to energy drink use.
Conclusions:
- Harm reduction offers a practical approach to managing unhealthy energy drink consumption.
- Patient education on potential harms is key, regardless of abstinence readiness.
- Clinical strategies should support incremental changes towards healthier behaviors.
More Related Videos
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...